http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-117557-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-46
filingDate 1996-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29fdeb329f0a9812633483d1ed52674f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7220e6be8c29c020fed0711921c25c91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f3a35bd6fc15f5317a1caa2689af385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df89ad17efbbbb2caf93ae1dd5fca42a
publicationDate 2004-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-117557-A
titleOfInvention 1-(1,2-disubstituted piperidinyl)-4- substituted piperidine derivatives
abstract THE PRESENT INVENTION CONCERNS COMPOUNDS OF FORMULA THE N-OXIDE FORMS, THE PHARMACEUTICALLY ACCEPTABLE ADDITION SALTS AND STEREOCHEMICALLY ISOMERIC FORMS THEREOF, WHEREIN N IS 0, 1 OR 2; M IS 1 OR 2, PROVIDED THAT IF M IS 2, THEN N IS 1; P IS 0, 1 OR 2; =Q IS =O OR =NR3; X IS A COVALENT BOND OR A BIVALENT RADICAL OF FORMULA -O-, -S-, -NR3-; R1 IS ARL; AR1C1-6ALKYL OR DI(AR1)C1-6ALKYL, WHEREIN EACH C1-6ALKYL GROUP IS OPTIONALLY SUBSTITUTED WITH HYDROXY, C1-4ALKYLOXY, OXO OR A KETALIZED OXO SUBSTITUENT OF FORMULA -O-CH2-CH2-O- OR -O-CHZ-CHZ-CH2-O-; R2 IS AR2; AR2C1-6ALKYL; HET OR HETC1-6ALKYL; R3 IS HYDROGEN OR C1-6ALKYL; R4 IS HYDROGEN; C1-4A1KY1; C1-4ALKYLOXYC1-4ALKYL; HYDROXYC1-4ALKYL; CARBOXYL; C1-4ALKYLOXYCARBONYL OR AR3; R5 IS HYDROGEN; HYDROXY; AR3; AR3C1-6ALKYLOXY; DI(AR3)C1-6ALKYLOXY; AR3C1-6ALKYLTHIO; DI(AR3)C1-6ALKYLTHIO; AR3C1-6ALKYLSULFOXY; DI(AR3)C1-6ALKYLSULFOXY; AR3C1-6ALKYLSULFONYL; DI(AR3)C1-6ALKYLSULFONYL; -NR7R8; C1-6A1KY1 SUBSTITUTED WITH -NR7R8; OR A RADICAL OF FORMULA (A-1) OR (A-2); R4 AND R5 MAY ALSO BE TAKEN TOGETHER; R6 IS HYDROGEN; HYDROXY; C1-6ALKYLOXY; C1-6ALKYL OR AR3C1-6ALKYL; AR1, AR2 AND AR3 ARE PHENYL OR SUBSTITUTED PHENYL; AR2 IS ALSO NAPHTALENYL; AND HET IS AN OPTIONALLY SUBSTITUTED MONOCYCLIC OR BICYCLIC HETEROCYCLE; AS SUBSTANCE P ANTAGONISTS; THEIR PREPARATION, COMPOSITIONS CONTAINING THEM AND THEIR USE AS A MEDICINE.
priorityDate 1995-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155

Total number of triples: 69.